Study finds new link between HRT and breast cancer risk in young women
An international team of researchers found that overall, the use of HRT – a treatment commonly used to alleviate menopause symptoms – was not connected to young-onset breast cancer. Then they looked at the specific type used.
Various types of HRT are available, containing different hormones, including oestrogen products, progestogen, or a combination of both.
These medicines can be taken or used in different ways and work by replacing the hormones oestrogen and progesterone, which can fall to lower levels as women approach the menopause.
The researchers found that oestrogen hormone therapy use appeared to decrease breast cancer risk, while oestrogen plus progestin therapy appeared to increase it.
Most studies examining the links between hormone therapy and breast cancer risk have been conducted in older women.
Previous work, which has focused on women who have already been through the menopause, suggests that oestrogen plus progestin hormone therapy is a risk factor for breast cancer.
But academics from the National Institute of Environmental Health Sciences in the US wanted to explore the risks among younger women on hormone therapy, who may take these drugs after gynaecological surgery or during perimenopause.
The new meta-analysis published in the journal Lancet Oncology examined data drawn from previous studies of 459,476 women aged 16 to 54 years old.
Some 2 per cent of this group (8,455) developed young-onset breast cancer, which means the disease was diagnosed before they were 55 years old.
And 15 per cent of women involved in the study reported using hormone therapy, with oestrogen plus progestin hormone therapy and oestrogen being the most common types.
They found that oestrogen hormone therapy appeared to reduce the risk of young breast cancer by 14 per cent, while oestrogen plus progestin therapy increased the risk by 10 per cent.
'Although the strength of these associations might vary by age at first use, duration of use, gynaecological surgery status, and other factors, unopposed oestrogen hormone therapy use appears to decrease breast cancer risk and oestrogen plus progestin therapy appears to increase breast cancer risk,' the authors wrote.
'The findings can be used to augment clinical recommendations for hormone therapy use in young women, for whom guidance was previously scarce.'
Commenting on the study, Dr Kotryna Temcinaite, head of research communications at the charity Breast Cancer Now, said: 'This large-scale study offers useful insights for women aged under 55 on how HRT (hormone replacement therapy) may influence their chances of developing breast cancer before the menopause.
'It found that oestrogen-only therapy was linked to a lower risk, while combined oestrogen and progesterone therapy was associated with a small increase in risk of developing breast cancer in some women – particularly when used for more than two years or in women who hadn't undergone surgery to remove their uterus or both ovaries.
'These results are largely in line with what we already know about taking HRT for menopausal symptoms and its effects on breast cancer risk – for most people, the risk of developing breast cancer because of taking HRT is small and is outweighed by the benefits.
'The risk is higher the longer you take it, and the risk is higher with combined HRT compared to oestrogen-only HRT.
'Taking HRT is a very personal decision and, as such, it's vital that everyone has the information they need on the benefits and risks, discusses them with their GP or specialist team and is supported to make the choice that's right for them.
'We'd encourage anyone with questions about HRT and their breast cancer risk to speak to their GP or to our expert nurses by calling our free, confidential Helpline on 0808 800 6000.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
33 minutes ago
- Daily Mail
Eight people hospitalized with deadly toxin after eating homemade food at family reunion
Eight people were hospitalized in California after eating a homemade salad that was contaminated with Clostridium botulinum - a deadly neurotoxin that can cause paralysis. A new CDC report detailed that on June 21 and June 22, 2024, about 31 people attended two events in Fresno County where a salad made of uncooked nopales - prickly pear cactus pads - was served. Within hours, a 42-year-old woman began to complain of dizziness, blurry vision, a drooping eyelid, sore throat, gastrointestinal symptoms and difficulty swallowing. Despite initially dismissing her symptoms, doctors began to suspect that she was suffering from botulism - a rare but serious poisoning that attacks the body's nerves and causes difficulty breathing, muscle paralysis and even death. By June 27, 10 attendees - all of whom had eaten the salad - had sought treatment at one of two hospitals in Fresno County (five patients at each hospital) for symptoms resembling those of botulism. As a result, the CDC, the Fresno County Department of Public Health and California Department of Public Health launched an investigation to discover the cause of the widespread illness. After days of lab testing, officials were ultimately able to discover that the uncooked nopales present in the salad - which had been left unrefrigerated in 100 degree Fahrenheit heat and served on both days - was contaminated with C botulinum. Soon after, eight of the 10 patients were diagnosed with the condition - marking it as one of the largest documented foodborne outbreaks of the infection in California. Nopales, a popular food in traditional Mexican dishes also known as prickly pear cactus, has recently gained popularity in dishes as a healthy ingredient. Officials confirmed that one of the eight patients had made the salad using fresh onions, fresh tomatoes and home-preserved nopales stored in reused commercial glass jars. According to the CDC case report, the salad-maker had immersed empty jars into boiling water and then added chopped, uncooked nopales mixed with a small amount of salt. Once stuffed to the brim, she sealed the jars with new metal lids and stored them for six weeks in an outdoor shed behind her house - a technique she said she had been practicing for years. However, she was unaware that she had created the perfect breeding ground for C botulinum spores as they thrive in a low-oxygen, low-acid, canned environment with moderate to high moisture and temperatures between 38F and 113F to grow. Norma Sanchez, communicable disease specialist with Fresno County Department of Public Health, later said they identified the contaminated cactus after sifting through trash cans. Spores of this bacteria are often found on the surfaces of fruits and vegetables and in seafood and, in this case, rapidly grew on the surface of the uncooked and canned nopales. All eight patients diagnosed with botulism had double vision, seven had a hoarse voice, six were experiencing dizziness and six also found it difficult to swallow. The eight patients with clinical botulism were the only attendees who ate the nopales salad; the 42-year-old woman, who experienced the most severe symptoms, ate this item at both events. As a result, all of the patients had to stay at the hospital for between two and 42 days - out of which six were admitted to an intensive care unit and two required invasive mechanical ventilation. The CDC later confirmed in its case report that all the people diagnosed with botulism had survived and recovered. Botulism is a rare but serious infection caused by a bacterial toxin that attacks the nervous system and is mostly commonly a result of food or wound contamination. Common symptoms of botulism include difficulty swallowing, muscle weakness, double vision, drooping eyelids, blurry vision, slurred speech, difficulty breathing, and trouble moving the eyes, according to the CDC. In cases of foodborne botulism, these symptoms of typically begin 12 to 36 hours after the toxin enters the body depending on the level of exposure to the toxin. If left untreated, the infection can cause muscle weakness, paralysis and in certain cases, death. Patients who are paralyzed need to relearn how to walk, talk, and perform everyday tasks. The CDC estimates that there are just 25 cases of foodborne botulism in the US each year, making it rare. About five percent of people who develop botulism die, according to the CDC. For others, it can cause lifelong disability and extreme physical therapy. The Fresno health department is urging people to follow proper storing and cooking methods to lower their risk of botulism. Any food at risk of contamination should be heated up to 240–250F, and heated all the way through.
Reuters
an hour ago
- Reuters
US Air Force suspends SpaceX rocket project on Pacific atoll, report says
WASHINGTON, July 4 (Reuters) - The U.S. Air Force has suspended plans it had proposed with Elon Musk's SpaceX to test hypersonic rocket cargo deliveries from a remote Pacific atoll, according to a report this week in Stars and Stripes, an independent publication of the U.S. military. The suspension came after Reuters reported that biologists and experts said the project would harm many seabirds that nest at the wildlife refuge on the Johnston Atoll, an unincorporated U.S. territory nearly 800 miles (1,300 km) southwest of Hawaii. The Air Force had said it would undertake an environmental assessment of the project, but publication of a draft assessment was delayed after opposition to the plan by environmental groups. The Air Force and SpaceX did not immediately respond to requests for comment. The Air Force is exploring alternative locations for the program, a spokesperson of the military branch told the Stars and Stripes newspaper in story published on Thursday. The program would use commercial rockets, such as those made by SpaceX, although the Air Force has not announced private partners. It would test landing rocket re-entry vehicles designed to deliver up to 100 tons of cargo to anywhere on Earth within about 90 minutes. The program would be a breakthrough for military logistics by making it easier to move supplies quickly into distant locations. But it could be too much for the island's 14 species of tropical birds to withstand, according to biologists and experts who have worked on the one-square-mile (2.6 square km) atoll, part of the Pacific Remote Islands Marine National Monument. SpaceX's activities have affected protected birds elsewhere. A SpaceX launch of its Starship rocket in Boca Chica, Texas, last year involved a blast that destroyed nests and eggs of plover shorebirds, landing the company of billionaire Musk in legal trouble and leading him to remark jokingly that he would refrain from eating omelets for a week to compensate.
Daily Mail
2 hours ago
- Daily Mail
Controversial but cheap supplement that millions already take beats dementia
Apart from helping you improve muscle growth, your protein powder may also protect your brain from decline and dementia. Researchers from the University of Kansas have found that consuming creatine as a supplement in any form can help improve memory and potentially reduce the risk of Alzheimer's disease. Usually found in the body's muscles, creatine is an organic compound made of amino acids (simple proteins) that is also found in the brain. It is produced by the liver, pancreas and kidneys and is critical in maintaining the brain's memory, attention span, energy production and processing speed. Previous research has shown that lower levels of creatine in the brain is associated with cognitive decline. And while low creatine levels are not a direct cause of dementia, they could lead to less energy production, which may worsen a person's memory. In a new study, scientists found that patients suffering from Alzheimer's disease who took 20 grams of creatine for eight weeks showed an 11 percent increase in their brain's creatine levels and a slight increase in cognitive and memory tests. Lead author Dr Matthew Taylor, assistant professor of dietetics and nutrition at KU School of Health Professions, said: 'There has been evidence in other populations that giving a higher dose of creatine does change brain creatine levels, but seeing it change in Alzheimer's patients was really exciting. That 11 percent is a significant increase.' Alzheimer's disease is one of the most common forms of dementia and mostly affects older adults. About 7.2million people in the US 65 and older live with the condition and over 100,00 die from it annually. The Alzheimer's Association estimates that by 2050, nearly 13 million Americans will be living with the condition. Creatine supplements, typically priced about $2.40 per serving and taken by as many as 20million Americans, are usually bought by those looking to enhance athletic performance and muscle growth. They are most commonly available in both capsules and powder form. For the trial, 19 Alzheimer's patients were given 20g of creatine monohydrate, a powder they could mix into a beverage of their choice, every day for eight weeks. According to experts, the standard dose of creatine recommended for people looking to boost their muscle strength and athletic performance is 5g per day. But since natural creatine produced in the body goes to the muscles first and whatever remains trickles to the brain, researchers gave patients 20g in hopes more would travel there. The participants also underwent blood tests, MRI scans and took cognitive evaluations before taking the supplement, after four weeks and again after eight weeks to measure creatine levels and memory and cognitive improvement. Along the 11 percent increase in brain creatine levels, results showed the participant's overall cognitive abilities, including attention, memory, language, and executive functions, slightly improved. Additionally, their capacity to think logically and problem-solve also increased marginally. The participants' ability to accurately and fluently read, as well as to pay attention to a singular object also showed significant improvement. The study authors wrote: 'The cognitive improvements observed in this study are also promising, as Alzheimer's disease is a progressive disease with expected decline over time. 'We hypothesized that memory and executive function, the most affected domains in Alzheimer's disease would benefit from creatine monohydrate supplementation.' Alzheimer's disease is believed to be caused by the development of amyloid plaques and tau tangles in the brain - which damage and kill cells. Amyloid protein molecules stick together in brain cells, forming clumps called plaques. While tau proteins twist together in fiber-like strands called tangles. The plaques and tangles block the ability of the brain's neurons to send electrical and chemical signals back and forth. Over time, this disruption causes permanent damage in the brain that leads to Alzheimer's disease. While there is no clear cause of the disease, experts believe it can develop due to genetic mutations and lifestyle choices, such as physical inactivity, unhealthy diet and social isolation. However, the scientists involved in this study also believe that low creatine levels can cause problems with the quantity of energy produced in the brain and how the organ uses it. Low energy levels due to a lack of creatine can significantly impair cognitive processes like attention, memory, and decision-making while also affecting mood and emotional regulation. This can increase the progression of Alzheimer's disease in individuals and worsen their ability to perform basic tasks. Therefore, the 11 percent increase in brain creatine levels observed in this study provides hope for Alzheimer's patients looking to slow down the progression of their condition. It remains unknown the exact relationship between creatine and dementia. Dr Taylor noted that additional research is needed to understand how the supplement can improve cognition. This not the first time scientists have uncovered the benefits of creatine supplements on the brain. A 2018 Experimental Gerontology found that taking the supplement orally may improve short-term memory, as well intelligence and logical reasoning in healthy adults. The 2025 study was published in Alzheimer's & Dementia: Translational Research & Clinical Intervention journal in May 2025. But creatine has also come under fire, suspected of leading to water retention, bloating and GI upset, hair loss and an increased risk of kidney damage.
